EGFR is a well-known proto-oncogene, and its hyperactivation via mutation and overexpression has been linked to tumor development and malignancy in various solid tumors, including lung cancer, breast cancer, and colon cancer [33]. This evidence concerns the gene EGFR and breast carcinoma.